Nishadil
Signup Signin
Delhi | 25°C (windy)
Citius Oncology's Lymphir: A New Chapter in the Fight Against Cutaneous T-Cell Lymphoma

Citius Oncology's Lymphir: A New Chapter in the Fight Against Cutaneous T-Cell Lymphoma
A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US
Soligenix's Breakthrough: Safety Success in T-Cell Lymphoma Trial Sparks Investor Frenzy and Multi-Day Rally Prospects

Soligenix's Breakthrough: Safety Success in T-Cell Lymphoma Trial Sparks Investor Frenzy and Multi-Day Rally Prospects
Soligenix Forges Ahead: Celebrating Groundbreaking Milestones and Robust Financial Growth in Q2 2024

Soligenix Forges Ahead: Celebrating Groundbreaking Milestones and Robust Financial Growth in Q2 2024
Soligenix Soars: Groundbreaking Progress and Robust Financials Propel Q2 2025 Success

Soligenix Soars: Groundbreaking Progress and Robust Financials Propel Q2 2025 Success
Load more..